We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

Back to rankings

44 hedge funds and large institutions have $9.36M invested in Biostage, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

2% more funds holding

Funds holding: 43 → 44 (+1)

9% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 11

62% less capital invested

Capital invested by funds: $24.3M → $9.36M (-$15M)

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
10
Reduced
11
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
California Public Employees Retirement System
California Public Employees Retirement System
California
+$149K
2
WIC
Woodmont Investment Counsel
Tennessee
+$117K
3
BIT
BlackRock Institutional Trust
California
+$86.6K
4
VKH
Virtu KCG Holdings
New York
+$64.9K
5
ARTA
A.R.T. Advisors
New York
+$56.7K

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$489K
2
HSA
Hussman Strategic Advisors
Maryland
-$344K
3
Morgan Stanley
Morgan Stanley
New York
-$332K
4
6CM
683 Capital Management
New York
-$240K
5
PAM
Panagora Asset Management
Massachusetts
-$198K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
Bard Associates
Illinois
$49K -$4.95K -1,000 -6%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$49K – – –
VKH
28
Virtu KCG Holdings
New York
$42K +$64.9K +13,109 New
ARTA
29
A.R.T. Advisors
New York
$36K +$56.7K +11,440 New
Bank of America
30
Bank of America
North Carolina
$32K – – –
KAM
31
Kazazian Asset Management
Florida
$25K +$38.1K +7,700 New
TRCT
32
Tower Research Capital (TRC)
New York
$20K +$30.5K +6,154 New
Deutsche Bank
33
Deutsche Bank
Germany
$17K +$24.8K +5,000 +812%
NFA
34
Nationwide Fund Advisors
Ohio
$7K -$669 -135 -6%
UBS Group
35
UBS Group
Switzerland
$6K +$8.95K +1,806 New
NYLIM
36
New York Life Investment Management
New York
$5K -$1.71K -346 -19%
Wells Fargo
37
Wells Fargo
California
$5K – – –
BIM
38
BlackRock Investment Management
Delaware
$4K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$3K – – –
Creative Planning
40
Creative Planning
Kansas
$3K +$5.01K +1,011 New
EARNEST Partners
41
EARNEST Partners
Georgia
$2K – – –
Citigroup
42
Citigroup
New York
$1K +$1.03K +209 +387%
BRWA
43
B. Riley Wealth Advisors
Florida
$10 +$15.4K +3,100 New
SM
44
Sabby Management
Florida
– -$451 -55,621 Closed
PAM
45
Panagora Asset Management
Massachusetts
– -$198K -24,468 Closed
PPA
46
Parametric Portfolio Associates
Washington
– -$186K -22,986 Closed
Barclays
47
Barclays
United Kingdom
– -$15K -1,846 Closed
LTFS
48
Ladenburg Thalmann Financial Services
Florida
– -$2.62K -529 -88%
Schroder Investment Management Group
49
Schroder Investment Management Group
United Kingdom
– -$1.94K -239 Closed
1
2

BSTG Hedge Fund Activity: Q4 2014 in Review

44 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2014, worth a combined $9.36M — down 62% from $24.3M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BSTG positions and 7 closed out — a net gain of 2 holders — while 10 added to existing stakes and 11 trimmed.

The largest buyer was California Public Employees Retirement System, adding an estimated $149K. The largest seller was Royce & Associates, cutting an estimated $489K.

  • 44 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2014, up from 43 in Q3 2014.
  • Funds reported $9.36M of Biostage, Inc. Common Stock stock for Q4 2014, down 62% quarter-over-quarter.
  • 9 funds opened new Biostage, Inc. Common Stock positions in Q4 2014 and 7 closed out, a net change of +2 holders.
  • The largest Biostage, Inc. Common Stock buyer in Q4 2014 was California Public Employees Retirement System, an estimated $149K added.
  • The largest Biostage, Inc. Common Stock seller in Q4 2014 was Royce & Associates, an estimated $489K sold.

Based on aggregated 13F filings for Q4 2014.